Inventor · disambiguated record
Seshidhar Reddy Police
Also filed as: POLICE SESHIDHAR REDDY
5 granted patents·13 pending applications·33 citations·filing 2002–2023
80Inventor score
Top patents by PatentIndex Score
18 records- 0187US9163259B2Viral vectors for the treatment of retinal dystrophyCHOI VIVIAN·Filed 2013·Granted Oct 20, 2015·16 cites·9 claims
- 0286US8039606B2Seneca Valley virus based compositions and methods for treating diseaseNOVARTIS AG·Filed 2009·Granted Oct 18, 2011·6 cites·3 claims
- 0385US9803217B2Viral vectors for the treatment of retinal dystrophyNOVARTIS AG·Filed 2015·Granted Oct 31, 2017·5 cites·12 claims
- 0483US8753622B2Seneca valley virus based compositions and methods for treating diseaseHALLENBECK PAUL·Filed 2011·Granted Jun 17, 2014·5 cites·5 claims
- 0577US2023323398A1Viral vectors for the treatment of retinal dystrophyNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0675US10550404B2Viral vectors for the treatment of retinal dystrophyNOVARTIS AG·Filed 2017·Granted Feb 4, 2020·1 cites·23 claims
- 0766US2024002843A1Compositions and methods for the treatment of hemoglobinopathiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0863US2021047656A1Viral vectors for the treatment of retinal dystrophyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0962US2024041757A1LIPID NANOPARTICLES (LNPs)-BASED OCULAR DELIVERYCRISPR THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 1061US2014348798A1Seneca valley virus based compositions and methods for treating diseaseNEOTROPIX INC·Filed 2014·Application pending·0 cites
- 1158US2025381304A1Methods and compositions for in vivo editing of stem cellsCRISPR THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 1254US2022056438A1Gene-editing compositions and methods to modulate faah for treatment of neurological disordersCRISPR THERAPEUTICS AG·Filed 2021·Application pending·0 cites
- 1353US2021032622A1Self-inactivating (sin) crispr/cas or crispr/cpf1 systems and uses thereofCRISPR THERAPEUTICS AG·Filed 2018·Application pending·0 cites
- 1452US2021363521A1CRISPR/CAS Systems For Treatment of DMDVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 1551US2021047649A1Crispr/cas all-in-two vector systems for treatment of dmdVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 1646US2023052011A1Regulatable expression systemsCRISPR THERAPEUTICS AG·Filed 2020·Application pending·0 cites
- 1742US2019010495A1Compositions and methods for the treatment of hemoglobinopathiesNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1839US2003104625A1Novel oncolytic adenoviral vectorsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →